Wedbush Securities Inc. Sells 1,773 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Wedbush Securities Inc. cut its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 13.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,296 shares of the pharmacy operator’s stock after selling 1,773 shares during the period. Wedbush Securities Inc.’s holdings in Walgreens Boots Alliance were worth $618,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in WBA. Family Legacy Inc. raised its position in shares of Walgreens Boots Alliance by 2.5% during the first quarter. Family Legacy Inc. now owns 8,020 shares of the pharmacy operator’s stock worth $442,000 after purchasing an additional 195 shares during the period. Hills Bank & Trust Co. raised its position in shares of Walgreens Boots Alliance by 5.5% during the first quarter. Hills Bank & Trust Co. now owns 3,815 shares of the pharmacy operator’s stock worth $242,000 after purchasing an additional 200 shares during the period. Plimoth Trust Co. LLC raised its position in shares of Walgreens Boots Alliance by 2.4% during the first quarter. Plimoth Trust Co. LLC now owns 8,379 shares of the pharmacy operator’s stock worth $530,000 after purchasing an additional 200 shares during the period. Cable Hill Partners LLC raised its position in shares of Walgreens Boots Alliance by 40.0% during the first quarter. Cable Hill Partners LLC now owns 700 shares of the pharmacy operator’s stock worth $44,000 after purchasing an additional 200 shares during the period. Finally, Exencial Wealth Advisors LLC raised its position in shares of Walgreens Boots Alliance by 1.0% during the first quarter. Exencial Wealth Advisors LLC now owns 20,134 shares of the pharmacy operator’s stock worth $1,274,000 after purchasing an additional 207 shares during the period. Institutional investors and hedge funds own 61.97% of the company’s stock.

WBA has been the topic of a number of research reports. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price on the stock. in a research report on Monday, June 10th. ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, June 28th. Morgan Stanley set a $61.00 target price on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Tuesday, May 14th. Finally, JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research report on Friday, June 28th. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $63.82.



NASDAQ WBA traded up $1.22 on Friday, reaching $50.51. The company had a trading volume of 79,319 shares, compared to its average volume of 4,470,581. The stock has a market capitalization of $47.93 billion, a P/E ratio of 8.38, a P/E/G ratio of 1.33 and a beta of 0.81. The company’s fifty day moving average is $54.27 and its 200 day moving average is $57.61. Walgreens Boots Alliance Inc has a 52-week low of $49.12 and a 52-week high of $86.31. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.05. The business had revenue of $34.59 billion during the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. Walgreens Boots Alliance’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.53 EPS. On average, research analysts expect that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be given a $0.458 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 dividend on an annualized basis and a yield of 3.63%. The ex-dividend date is Monday, August 19th. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: Systematic Risk and Investors

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.